Chloroquine: Ophthalmological Safety, and Clinical Assessment in Rheumatoid Arthritis

Abstract

272 patients on long-term chloroquine therapy were assessed with respect to ocular toxicity and clinical benefit A simple scheme for rendering patients ophthalmologically safe is presented, employing the recording of central fields to red targets. Under this it was possible to diagnose a state of premaculopathy, which was reversible on stopping treatment The incidence of premaculoliathy was 41% in 143 patients who otherwise displayed no abnormality of the fundus oculi and who had received a mean total dose of 410 g. of chloroquine phosphate or the hydroxychloroquine sulphate equivalent. Under this joint ophthalmological and rheumatological supervision it was considered that the minor side-effects that may be caused by chloroquine are outweighed by its therapeutic value. © 1968, British Medical Journal Publishing Group. All rights reserved.